rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter

PHASE2CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

July 31, 2005

Conditions

Benign Nontoxic and Toxic GoiterGraves' Disease

Interventions

DRUG

Recombinant human thyrotropin (Thyrogen)

Trial Locations (1)

Department of Endocrinology, Odense University Hospital, Odense

All Listed Sponsors

lead

Odense University Hospital

OTHER

NCT00145366 - rhTSH, Thyroid Size, and Radioiodine Therapy in Benign Goiter | Biotech Hunter | Biotech Hunter